ESC 365 - Lipoprotein(a) is not associated with survival after acute coronary syndromes

ESC Premium Access

Lipoprotein(a) is not associated with survival after acute coronary syndromes

Session: Poster Session 5 - Biomarkers lipid glucose

Topic: Epidemiology, Prognosis, Outcome

Speaker: Doctor C. Roth (Vienna, AT)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Doctor Christian Roth

Inernisten am Elterleinlaz, Vienna (Austria)

0 follower

4 more presentations in this session

Differential prognostic impact of blood glucose levels at the acute stage of myocardial infarction according to HbA1c. The FAST-MI programme

Speaker: Professor N. Danchin (Paris, FR)

Prognostic interest of HbA1c and plasma glucose assessment on one-year mortality in non-diabetic patients after acute myocardial infarction

Speaker: Doctor E. Ratheau (Dijon, FR)

PFA-100, a test of platelet adhesion/aggregation, predicts cardiovascular events after an acute coronary syndrome and can help in the decision-making for dual antiplatelet extension

Speaker: Doctor S. Chiappino (Massa, IT)

In patients with acute myocardial infarction, PCSK9 levels do not predict severity and recurrence of cardiovascular events

Speaker: Professor M. Zeller (Dijon, FR)

Access the full session

Poster Session 5 - Biomarkers lipid glucose

Speakers: Doctor C. Roth, Professor N. Danchin, Doctor E. Ratheau, Doctor S. Chiappino, Professor M. Zeller

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources